SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

BRIEF-Axcella Announces Initiation Of EMMPACTSM Phase 2B Clinical Trial Of AXA1125

05/11/2021 08:48
BRIEF-Axcella Announces Initiation Of EMMPACTSM Phase 2B Clinical Trial Of AXA1125

- Axcella Health Inc AXLA.O:

  • AXCELLA ANNOUNCES INITIATION OF EMMPACTSM PHASE 2B CLINICAL TRIAL OF AXA1125

  • AXCELLA HEALTH INC - INITIAL CLINICAL SITES ACTIVATED AND PATIENT SCREENING UNDERWAY

  • AXCELLA HEALTH INC - POTENTIAL FOR AXA1125 TO SERVE AS A FIRST-LINE THERAPY FOR PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS

Source text for Eikon: ID:nBwbXDs7ma

Further company coverage: AXLA.O


(([email protected];))